|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$1.01 |
$1.02 |
$1.00 |
$1.00 |
125.30K | 03/25/2024 |
$1.02 |
$1.03 |
$1.01 |
$1.03 |
182.80K | 03/26/2024 |
$1.03 |
$1.03 |
$1.00 |
$1.01 |
105.50K | 03/27/2024 |
$1.03 |
$1.03 |
$1.00 |
$1.03 |
132.10K | 03/28/2024 |
$1.04 |
$1.06 |
$1.01 |
$1.06 |
294.20K |
|
Oncolytics Biotech is a development stage biopharmaceutical company that focuses on the discovery and development of pharmaceutical products for the treatment of cancers. Co.'s primary product, pelareorep, is an immuno-oncology viral-agent that may be a treatment for certain types of cancer and may be an alternative to or used in combination with existing cytotoxic or cytostatic therapies. Co.'s clinical development program for pelareorep centers on main immunotherapy combinations. Immunotherapy combinations in which pelareorep has the potential to provoke specific innate and adaptive immune responses when combined with checkpoint blockade therapy, chemotherapy and/or targeted therapies. | |
|
Oncolytics Biotech (ONCY) has the following price history information. Looking back at ONCY historical stock prices for the last five trading days, on March 22, 2024, ONCY opened at $1.01, traded as high as $1.02 and as low as $1.00, and closed at $1.00. Trading volume was a total of 125.30K shares. On March 25, 2024, ONCY opened at $1.02, traded as high as $1.03 and as low as $1.01, and closed at $1.03. Trading volume was a total of 182.80K shares. On March 26, 2024, ONCY opened at $1.03, traded as high as $1.03 and as low as $1.00, and closed at $1.01. Trading volume was a total of 105.50K shares. On March 27, 2024, ONCY opened at $1.03, traded as high as $1.03 and as low as $1.00, and closed at $1.03. Trading volume was a total of 132.10K shares. On March 28, 2024, ONCY opened at $1.04, traded as high as $1.06 and as low as $1.01, and closed at $1.06. Trading volume was a total of 294.20K shares.
ONCY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Oncolytics Biotech shares, starting with a $10,000 purchase of ONCY, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$17.67 |
|
End price/share: |
$1.06 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-94.00% |
|
Average Annual Total Return: |
-24.53% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$599.90 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/22/2024 | $1.00 | 03/25/2024 | $1.03 | 03/26/2024 | $1.01 | 03/27/2024 | $1.03 | 03/28/2024 | $1.06 |
|
|